HIMSS Director of Informatics Mari Greenberger says that as pilot tests move into production healthcare organizations should rally around a use case and understand who needs to be involved to reduce redundancies and eliminate sunk costs.

David Stefanich, managing partner and CEO of Rymedi, discusses how his company works to capture, track and share data across value chains in the life sciences industry and gives examples of programs currently in production in Mongolia and the US.

Tej Anand, professor of practice at the University of Texas' McCombs School of Business, explains how the most promising use case for blockchain in healthcare is the elimination of "redundant work, rework and reconciliation."

Susanne Somerville, CEO of Chronicled, discusses the MediLedger Network, a blockchain solution that provides product verification to help organizations meet requirements outlined in the upcoming Drug Supply Chain Security Act (DSCSA).

Blockchain ensures greater data integrity in areas such as AI, analytics and regulatory reporting, which can increase public confidence in the use of data, according to Raja Sharif, CEO, FarmaTrust.

Data ownership, access and control, in addition to consent management, are just a few of the benefits that blockchain can provide in healthcare, says Mirko De Maldè, President at Government Blockchain Association Italy.